Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.
Zhu Y, Banerjee A, Xie P, Ivanov AA, Uddin A, Jiao Q, Chi JJ, Zeng L, Lee JY, Xue Y, Lu X, Cristofanilli M, Gradishar WJ, Henry CJ, Gillespie TW, Bhave MA, Kalinsky K, Fu H, Bahar I, Zhang B, Wan Y. Zhu Y, et al. Among authors: cristofanilli m. J Clin Invest. 2024 Mar 26;134(10):e176390. doi: 10.1172/JCI176390. J Clin Invest. 2024. PMID: 38530357 Free PMC article.
Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer.
Shah D, Wells A, Cox M, Dawravoo K, Abad J, D'Souza A, Suh G, Bayer R, Chaudhry S, Zhang Q, Cristofanilli M, Bentrem D, Chawla A. Shah D, et al. Among authors: cristofanilli m. Ann Surg. 2024 Jan 23:10.1097/SLA.0000000000006209. doi: 10.1097/SLA.0000000000006209. Online ahead of print. Ann Surg. 2024. PMID: 38258582
[No title available]
[No authors listed] [No authors listed] PMID: 36892508
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
Nicolò E, Tarantino P, D'Ecclesiis O, Antonarelli G, Boscolo Bielo L, Marra A, Gandini S, Crimini E, Giugliano F, Zagami P, Corti C, Trapani D, Morganti S, Criscitiello C, Locatelli M, Belli C, Esposito A, Minchella I, Cristofanilli M, Tolaney SM, Curigliano G. Nicolò E, et al. Among authors: cristofanilli m. Oncologist. 2024 Jan 5;29(1):75-83. doi: 10.1093/oncolo/oyad212. Oncologist. 2024. PMID: 37548439 Free PMC article. Review.
Inflammatory breast cancer: Epidemiologic data and therapeutic results.
Boussen H, Berrazaga Y, Sherif Kullab, Manai M, Berrada N, Mejri N, Siala I, Levine PH, Cristofanilli M. Boussen H, et al. Among authors: cristofanilli m. Int Rev Cell Mol Biol. 2024;384:1-23. doi: 10.1016/bs.ircmb.2023.10.003. Epub 2024 Feb 6. Int Rev Cell Mol Biol. 2024. PMID: 38637094 Review.
461 results